Matches in Wikidata for { <http://www.wikidata.org/entity/Q92656894> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q92656894 description "2019 թվականի սեպտեմբերի 11-ին հրատարակված գիտական հոդված" @default.
- Q92656894 description "article scientifique publié en 2019" @default.
- Q92656894 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q92656894 description "scientific article published on 11 September 2019" @default.
- Q92656894 description "wetenschappelijk artikel" @default.
- Q92656894 description "наукова стаття, опублікована 11 вересня 2019" @default.
- Q92656894 name "Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial" @default.
- Q92656894 name "Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial" @default.
- Q92656894 type Item @default.
- Q92656894 label "Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial" @default.
- Q92656894 label "Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial" @default.
- Q92656894 prefLabel "Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial" @default.
- Q92656894 prefLabel "Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial" @default.
- Q92656894 P1433 Q92656894-F6FC8D9D-BB31-4F68-B27C-892D9F913EDF @default.
- Q92656894 P1476 Q92656894-FE2EF9AC-B2FD-4494-8A36-0BDFB137248A @default.
- Q92656894 P2093 Q92656894-24509671-66AE-4AE3-827D-6A584FA8E7AB @default.
- Q92656894 P2093 Q92656894-8F605070-EE23-4047-B25A-9D2B73F19E3B @default.
- Q92656894 P2093 Q92656894-9E7E8169-49AA-40B2-92BD-01CCCA82502C @default.
- Q92656894 P2093 Q92656894-A3E3657B-2397-4509-B4B8-AB085FBF2E75 @default.
- Q92656894 P2093 Q92656894-AA7B5C92-FB8D-4759-A238-2B354032307F @default.
- Q92656894 P2093 Q92656894-B215C3E4-1AEB-43F9-A38B-6E6D52F5AD94 @default.
- Q92656894 P2093 Q92656894-B8BD9120-EBF2-4B53-BE1A-B68A1B7B743B @default.
- Q92656894 P2093 Q92656894-F9DA7842-C222-4A6C-B0B5-56851F48ECEA @default.
- Q92656894 P275 Q92656894-5A707157-2AF9-4F6D-ADDE-6DB7D4C9EA1D @default.
- Q92656894 P304 Q92656894-5D12D42F-23A1-4C89-96BA-75D41A5D4862 @default.
- Q92656894 P31 Q92656894-6E17C9B3-ED36-41F1-BF31-D15E9D07B18C @default.
- Q92656894 P356 Q92656894-57BD7A22-9936-4526-B234-B67020469DFA @default.
- Q92656894 P433 Q92656894-F862A932-D909-454E-8193-7912D6DE4248 @default.
- Q92656894 P478 Q92656894-84C23184-E088-4241-9102-247879FC255B @default.
- Q92656894 P577 Q92656894-3CD9F9D3-5397-429B-B212-D683DF86C88E @default.
- Q92656894 P6216 Q92656894-FE274C1D-CDF9-46ED-A4FE-6D6A9DEE5734 @default.
- Q92656894 P698 Q92656894-0FF21D3D-B974-4C54-B3E7-ACC5B03CF27B @default.
- Q92656894 P921 Q92656894-46D3380E-C1C0-46A2-830F-8F85F44D171F @default.
- Q92656894 P356 03007995.2019.1656955 @default.
- Q92656894 P698 31418585 @default.
- Q92656894 P1433 Q5195063 @default.
- Q92656894 P1476 "Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial" @default.
- Q92656894 P2093 "Bruce H Mitlak" @default.
- Q92656894 P2093 "Christine Dabrowski" @default.
- Q92656894 P2093 "Gary Hattersley" @default.
- Q92656894 P2093 "John P Bilezikian" @default.
- Q92656894 P2093 "Lorraine A Fitzpatrick" @default.
- Q92656894 P2093 "Ming-Yi Hu" @default.
- Q92656894 P2093 "Paul D Miller" @default.
- Q92656894 P2093 "Socrates E Papapoulos" @default.
- Q92656894 P275 Q24082749 @default.
- Q92656894 P304 "2097-2102" @default.
- Q92656894 P31 Q13442814 @default.
- Q92656894 P356 "10.1080/03007995.2019.1656955" @default.
- Q92656894 P433 "12" @default.
- Q92656894 P478 "35" @default.
- Q92656894 P577 "2019-09-11T00:00:00Z" @default.
- Q92656894 P6216 Q50423863 @default.
- Q92656894 P698 "31418585" @default.
- Q92656894 P921 Q42824827 @default.